In fact, to our knowledge only TP53 and SMARCA4 have been implicated as possible tRCC driver genes in more than one study (29, 30, 42, 74, 75). Here, SMARCA4 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.